Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference160 articles.
1. Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL;Abramson;J. Clin. Oncol.,2018
2. Strategies to address chimeric antigen receptor tonic signaling;Ajina;Mol. Cancer Ther.,2018
3. CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells;Alcantara;Leukemia,2018
4. The european medicines agency review of kymriah (Tisagenlecleucel) for the treatment of acute lymphoblastic leukemia and diffuse large B-Cell lymphoma;Ali;Oncologist,2020
5. IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype;Alizadeh;Cancer Immunol. Res.,2019
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Editorial: Novel insights into CAR T-cell associated neurotoxicity;Frontiers in Neurology;2023-11-07
2. Chimeric Antigen Receptor T Cells: Immunotherapy for the Treatment of Leukemia, Lymphoma, and Myeloma;Molecular Cancer Therapeutics;2023-08-18
3. How I treat refractory/relapsed diffuse large B‐cell lymphomas with CD19‐directed chimeric antigen receptor T cells;British Journal of Haematology;2023-03-14
4. Microraft arrays for serial‐killer CD19 chimeric antigen receptor T cells and single cell isolation;Cytometry Part A;2022-08-08
5. The importance of molecular structure and functionalization of oxo-graphene sheets for gene silencing;Carbon;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3